Literature DB >> 5938056

Effects of allopurinol, a xanthine oxidase inhibitor, and sulfinpyrazone upon the urinary and serum urate concentrations in eight patients with tophaceous gout.

E Goldfarb, C J Smyth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5938056     DOI： 10.1002/art.1780090306

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

1.  Latest evidence on gout management: what the clinician needs to know.

Authors:  Christopher M Burns; Robert L Wortmann
Journal:  Ther Adv Chronic Dis       Date:  2012-11       Impact factor: 5.091

2.  A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties.

Authors:  Andrew C Nyborg; Chris Ward; Anna Zacco; Benoy Chacko; Luba Grinberg; James C Geoghegan; Ryan Bean; Michaela Wendeler; Frank Bartnik; Ellen O'Connor; Flaviu Gruia; Vidyashankara Iyer; Hui Feng; Varnika Roy; Mark Berge; Jeffrey N Miner; David M Wilson; Dongmei Zhou; Simone Nicholson; Clynn Wilker; Chi Y Wu; Susan Wilson; Lutz Jermutus; Herren Wu; David A Owen; Jane Osbourn; Steven Coats; Manuel Baca
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

Review 3.  Allopurinol for chronic gout.

Authors:  Rakhi Seth; Alison S R Kydd; Rachelle Buchbinder; Claire Bombardier; Christopher J Edwards
Journal:  Cochrane Database Syst Rev       Date:  2014-10-14

Review 4.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

5.  Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase.

Authors:  Brian F Mandell; Anthony E Yeo; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2018-12-29       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.